Tibet Cheezheng Tibetan Medicine Co Ltd Cash Flow Quality Index
Tibet Cheezheng Tibetan Medicine Co Ltd cash flow quality index. Tibet Cheezheng Tibetan Medicine Co Ltd (002287) has a Cash Flow Quality Index of 0.53x as of September 2025. Operating cash flow of CN¥34.69 Million is below net income of CN¥65.12 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 002287 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Tibet Cheezheng Tibetan Medicine Co Ltd (2006–2025)
Cash flow quality index of Tibet Cheezheng Tibetan Medicine Co Ltd from 2006 to 2025. Historical Cash Flow Quality Index for Tibet Cheezheng Tibetan Medicine Co Ltd across 20 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Tibet Cheezheng Tibetan Medicine Co Ltd (002287) net asset quality to measure how much of total assets are equity-financed.
Tibet Cheezheng Tibetan Medicine Co Ltd Cash Flow Quality Index by Year (2006–2025)
Tibet Cheezheng Tibetan Medicine Co Ltd cash flow quality index by year from 2006 to 2025. Year-by-year earnings quality comparison for Tibet Cheezheng Tibetan Medicine Co Ltd. For the full cash flow conversion analysis, see 002287 cash flow metrics.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.13x | CN¥729.70 Million | CN¥648.43 Million | ▲ +43.2% |
| 2024 | 0.79x | CN¥456.75 Million | CN¥581.37 Million | ▼ -34.4% |
| 2023 | 1.20x | CN¥693.41 Million | CN¥579.18 Million | ▲ +96.8% |
| 2022 | 0.61x | CN¥285.69 Million | CN¥469.51 Million | ▼ -58.2% |
| 2021 | 1.46x | CN¥1.03 Billion | CN¥710.83 Million | ▲ +147.6% |
| 2020 | 0.59x | CN¥238.65 Million | CN¥405.92 Million | ▼ -47.2% |
| 2019 | 1.11x | CN¥405.95 Million | CN¥364.39 Million | ▼ -29.2% |
| 2018 | 1.57x | CN¥499.40 Million | CN¥317.44 Million | ▲ +105.9% |
| 2017 | 0.76x | CN¥229.83 Million | CN¥300.77 Million | ▼ -43.5% |
| 2016 | 1.35x | CN¥389.20 Million | CN¥287.79 Million | ▲ +37.1% |
| 2015 | 0.99x | CN¥257.81 Million | CN¥261.36 Million | ▼ -25.3% |
| 2014 | 1.32x | CN¥310.95 Million | CN¥235.47 Million | ▲ +40.5% |
| 2013 | 0.94x | CN¥198.48 Million | CN¥211.17 Million | ▲ +4.0% |
| 2012 | 0.90x | CN¥169.67 Million | CN¥187.80 Million | ▲ +1413.6% |
| 2011 | -0.07x | CN¥-11.74 Million | CN¥170.65 Million | ▼ -112.1% |
| 2010 | 0.57x | CN¥96.91 Million | CN¥170.59 Million | ▼ -47.9% |
| 2009 | 1.09x | CN¥175.58 Million | CN¥161.18 Million | ▲ +124.6% |
| 2008 | 0.48x | CN¥65.93 Million | CN¥135.95 Million | ▼ -38.5% |
| 2007 | 0.79x | CN¥91.43 Million | CN¥115.93 Million | ▲ +113.8% |
| 2006 | 0.37x | CN¥38.50 Million | CN¥104.35 Million | — |